IPSWICH, Mass., June 26, 2012 /PRNewswire/ -- New England Biolabs, Inc. (NEB) and Academic Concept Knowledge, Ltd. (AQnowledge) announced their collaboration to increase the depth of interactive content in peer-reviewed scientific literature.
"Links between data and narrative are too often lost in the current format of a published scientific paper. Reading PDFs of papers in Utopia Documents helps restore that connection by enabling links to numerous public databases, as well as many other interactions, based upon semantic tagging of the text," said Andy Bertera, Executive Director of Marketing at New England Biolabs. "New England Biolabs is supporting improvements to the interactivity of scientific literature by providing data about our library of molecular biology reagents and their applications."
Utopia Documents is a free program already used by more than 22,000 scientists to transform any scientific literature in PDF format into an interactive document. For example, Utopia Document's semantic tagging engine allows tools and reagents cited in the methods section to be linked to the manufacturer's product page within one or two mouse clicks. Utopia Documents also connects literature to underlying public datasets, provides ways to export and graph tabular data, enables manipulation of molecular structures and sequence data, and changes references into hyperlinks. A special figure browser helps researchers scan papers in less time. The program also identifies the latest and trending papers using live data from Altmetric Mendeley, CrossRed, Scibite, and others.
Utopia Documents 2.0 is optimized for the life sciences, but can be used by scientists in any discipline. Utopia Documents is available for Macintosh, Windows and (shortly) Linux at: http://utopiadocs.com.
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and six subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs visit www.neb.com.
SOURCE New England Biolabs